Search
+

    India among 20 countries interested in obtaining Covid-19 vaccine from Russia

    Synopsis

    RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines, and start mass production in other countries in partnership with local sovereign wealth funds, including India, South Korea and Brazil, as well as, in Saudi Arabia, Turkey and Cuba, according to the statement.

    Agencies
    The vaccine was named 'Sputnik V' in reference to the 1957 launch of a Soviet satellite, which opened space to exploration by humans.
    Coronavirus

    COVID-19 CASES

    Confirmed
    5,646,010
    Deaths
    90,020
    NEW DELHI: Russia will begin mass production of the Sputnik V or Covid-19 vaccine in September, and India is among 20 countries which has expressed interest in obtaining it.

    Russia Development Investment Fund or RDIF (Russia’s sovereign wealth fund) finances the production of the Sputnik V in Russia on the basis of production capacities of its portfolio companies, R-Pharm and Binnopharm, a part of the Alium Group, according to Russian government statement.

    RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Arabia, United Arab Emirates (UAE), Brazil, India and Philippines, and start mass production in other countries in partnership with local sovereign wealth funds, including India, South Korea and Brazil, as well as, in Saudi Arabia, Turkey and Cuba, according to the statement.

    The plan is to ramp up the vaccine production to 200 million doses by the end of 2020 including 30 million doses in Russia.

    At least 20 countries had expressed interest in obtaining the Sputnik V, including UAE, Saudi Arabia, Indonesia, Philippines, Mexico, Brazil and India.

    Russia has become the first country in the world to register a vaccine against COVID-19, President Vladimir Putin announced on Tuesday during a government meeting.

    The vaccine was named 'Sputnik V' in reference to the 1957 launch of a Soviet satellite, which opened space to exploration by humans.

    The Russian president has asked Health Minister Mikhail Murashko to keep him informed about the vaccine, while at the same time noting that he knows "it works quite effectively" and "forms a stable immunity”

    The Russian president also revealed that one of his daughters had been vaccinated against the virus.

    Murashko has said that the first Russian vaccine against COVID-19 will begin to be produced at two sites - the Gamaleya Research Institute and the company Binnopharm.
    (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

    16 Comments on this Story

    srinivas42 days ago
    Simple formula - Entire North & East should go for Russian make & the West & South from the US/UK!
    Dr. Amitabha De42 days ago
    As per our present knowledge both AstraZeneca and Novavax COVID-19 VACCINES are the best.
    On the otherhand,WHO Already Cautions RUSSIA,that they should not Compromise on Safety.
    Babji Babji42 days ago
    Using on his own daughter is greate.
    The Economic Times